HBsAg浓度对HBeAg阳性的慢性乙型肝炎患者恩替卡韦治疗效果的预测价值
王洁 朱姣娜 陈公英 刘静 龚玲 施军平[關键词] 慢性乙型肝炎;慢性乙型肝炎表面抗原;肝炎e抗原;恩替卡韦;预测价值
[中图分类号] R512.62? ? ? ? ? [文献标识码] A? ? ? ? ? [文章编号] 1673-9701(2021)16-0027-05
The predictive value of HBsAg concentration on the therapeutic effect of entecavir in HBeAg-positive chronic hepatitis B patients
WANG Jie1? ?ZHU Jiaona2? ?CHEN Gongying1? ?LIU Jing1? ?GONG Ling1? ?SHI Junping1
1.The Affiliated Hospital of Hangzhou Normal University, Hangzhou? ?310000, China; 2.Ningbo Yinzhou NO.2 Hospital,Ningbo? ?315000, China
[Abstract] Objective To dynamically monitor the hepatitis B surface antigen (HBsAg) level in patients with hepatitis B e antigen (HBeAg) positive chronic hepatitis B (CHB) receiving entecavir (ETV) treatment, and to explore the predictive value of the early HBsAg concentration for treatment effect. Methods A total of 62 HBeAg-positive patients with chronic hepatitis B received entecavir antiviral treatment for one year. The hepatitis B virus (HBV) serum markers ......
您现在查看是摘要页,全文长 12044 字符。